Register By April 1st and Save Up To
$200
Michael
Levy, HOW TO MAKE ALLIANCES WORK-
aAchieving a Collaborative
Corporate Mindset
Special Pre-Conference
Workshop: "A very useful forum to learn about
the continuing evolution
Vice President,
Corporate and
Business
Development,
Bristol-Myers
Squibb
Thomas Hofstaetter,
Ph.D.,
Senior Vice
President,
Corporate and
Business
Development,
Wyeth
Guy
Eiferman,
Vice President,
Alliance
Management,
Merck &
Co.
Gregg Stetsko,
Ph.D.,
Vice
President,
Operations,
Amylin
Pharmaceuticals
Mark Della
Porta,
Senior Director and Site
Head, Strategic
Alliances,
Pfizer Global
R&D
William
Mongan,
Senior Director,
Licensing
Partnerships and
Commercial
Development,
AstraZeneca
Celia Gately,
Ph.D., Global
Alliance Director,
F. Hoffmann-La Roche
Ltd.
Michele Keough,
Director
of Programs
Management,
Genzyme
Richard B. Chapas,
Ph.D.
Director,
Industry
Collaboration,
Battelle
Steven
Roy,
Senior Associate
Director,
Licensing, Amgen,
Inc.
Ian McKenna,
Office
of Alliance
Management, Eli
Lilly
Anna Matranga,
Head
of Contracts
Management
and
Benchmarking,
Allergan
Glen Y. Sato,
Senior Vice
President and CFO,
Protein Design Labs,
Inc.
Damian Marron
Vice
President,
Business
Development,
NicOx
S.A
Rod Ray,
Ph.D., President,
Bend Research
Inc.
Pauline Jen
Ryan,
Corporate Development
&
Operations,
ImmunoGen,
Inc.
Corporate Sponsors:
A UNIQUELY INTERACTIVE
FORUM
REGISTER
TODAY
DOWNLOAD FINAL
BROCHURE
featured joint partner presenters for the 2nd
Alliance Management
Congress, taking place May 4-5 at the
Hyatt Penn's Landing in
Philadelphia, PA.
These
speakers will give it to you straight -- the qualities each
sought
in the other, how the alliance has changed over the
course of the part-
nership, hurdles they've overcome, what
they'd do differently -- these
are NOT pitches for the
capabilities of their respective companies, but
rather
straight-from-the-hip experiences and lessons learned, in an
interactive, give-and-take forum. Don't miss this chance
to learn how
you can improve the performance of your own
alliance!
Joint Partner
Presentation #1
Wednesday, May
4th
Celia Gately, Ph.D., Global Alliance
Director,
F. Hoffmann-La Roche
Ltd.
and
Glen Y.
Sato, Senior Vice President and Chief Financial Officer,
Protein Design Labs, Inc.
Joint Partner Presentation
#2
Thursday, May 5th
Mark
Della Porta, Senior Director and Site Head, Strategic
Alliances,
Pfizer Global
R&D
and
Rod
Ray, Ph.D., President, Bend Research
Inc.
aRemoving Barriers: The Challenge
of Conflict Management
aWho are the Right People for Your
Alliance Management Group?
aSparking Collaborative
Innovation
aOvercoming
Cultural Differences
...and
more!
You've Closed the
Deal, Now What?
The Essentials of Creating a High-Performing
Partnership
Facilitated
by JMW Consultants
Inc.
of this new and
important function, including networking
with
the leaders in the Alliance Management
area"
Pamela
R. Demain
Executive Director,
Corporate Licensing
Merck & Co.,
Inc.
Lead Sponsoring
Publications:

Media
Partners:
Sponsorship Information
To discuss your objectives
and explore easy to take an active role in
this executive
forum contact Arnie
Wolfson at 617-630-1331
or awolfson@healthtech.com
http://www.healthtech.com/2005/ams/index.asp
If the above
information is not of interest to you, please disregard and we apologize for any
inconvenience
this may have caused. Cambridge Healthtech Institute, 1037 Chestnut Street,
Newton Upper Falls, MA 02464 www.healthtech.com
|
This email has been circulated by BioPortfolio Ltd on behalf of Cambridge Healthtech Institute Inc. As a registered user of the BioPortfolio web sites, you were selected to receive this message in the genuine belief that it would be of interest to you. Subscriber
information: To unsubscribe to the BioPortfolio Bulletin click here and send. If your email has changed please email peter.barfoot@bioportfolio.com with a list of your email addresses and we will manually unsubscribe for you. Thank you for your understanding. Disclaimer: |
|
|
|
BioPortfolio is the essential web resource for scientists, executives, investors, the public and the patient with an interest in who, what, where, when and why biotechnology will impact on our lives. We have created proprietary databases and search engines that will support your business and private interests in the most exiting technology of the 21st Century. BioPortfolio provides 14 Channels: www.bioportfolio.com/ BioPortfolio Limited, Wessex Barn, Frampton, Dorset, DT2 9NB, UK |